<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is associated with Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, opportunistic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in immunocompromised hosts, and a fraction of <z:hpo ids='HP_0012126'>gastric cancers</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Aberrant promoter methylation accompanies human gastric <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, though the contribution of EBV to such somatic methylation changes has not been fully clarified </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed promoter methylation in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> cases with Illumina's Infinium BeadArray and used hierarchical clustering analysis to classify <z:hpo ids='HP_0012126'>gastric cancers</z:hpo> into 3 subgroups: EBV(-)/low methylation, EBV(-)/high methylation, and EBV(+)/high methylation </plain></SENT>
<SENT sid="3" pm="."><plain>The 3 epigenotypes were characterized by 3 groups of genes: genes methylated specifically in the EBV(+) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (e.g., CXXC4, TIMP2, and PLXND1), genes methylated both in EBV(+) and EBV(-)/high <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (e.g., COL9A2, EYA1, and ZNF365), and genes methylated in <z:hpo ids='HP_0000001'>all</z:hpo> of the <z:hpo ids='HP_0012126'>gastric cancers</z:hpo> (e.g., AMPH, SORCS3, and AJAP1) </plain></SENT>
<SENT sid="4" pm="."><plain>Polycomb repressive complex (PRC) target genes in embryonic stem cells were significantly enriched among EBV(-)/high-methylation genes and commonly methylated <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> genes (P = 2 × 10(-15) and 2 × 10(-34), respectively), but not among EBV(+) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-specific methylation genes (P = 0.2), suggesting a different cause for EBV(+)-associated de novo methylation </plain></SENT>
<SENT sid="5" pm="."><plain>When recombinant EBV was introduced into the EBV(-)/low-methylation epigenotype <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> cell, MKN7, 3 independently established subclones displayed increases in DNA methylation </plain></SENT>
<SENT sid="6" pm="."><plain>The promoters targeted by methylation were mostly shared among the 3 subclones, and the new methylation changes caused gene repression </plain></SENT>
<SENT sid="7" pm="."><plain>In summary, DNA methylation profiling classified <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> into 3 epigenotypes, and EBV(+) <z:hpo ids='HP_0012126'>gastric cancers</z:hpo> showed distinct methylation patterns likely attributable to <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
</text></document>